What is the current Orion Oyj market capitalization?
The current market capitalization of Orion Oyj is 6.91 B EUR.
Orion Oyj Market capitalization 2024
Orion Oyj Market capitalization
6.91 B EUR
Ticker
ORNBV.HE
ISIN
FI0009014377
WKN
A0J3QM
In 2024, Orion Oyj's market cap stood at 6.91 B EUR, a 30.71% increase from the 5.29 B EUR market cap in the previous year.
The Orion Oyj Market capitalization history
| YEAR | Market Capitalization (undefined EUR) |
|---|---|
| 2023 | 5.68 |
| 2022 | 5.99 |
| 2021 | 5.06 |
| 2020 | 5.69 |
| 2019 | 4.71 |
| 2018 | 3.99 |
| 2017 | 6.28 |
| 2016 | 4.79 |
| 2015 | 4.45 |
| 2014 | 3.6 |
| 2013 | 2.8 |
| 2012 | 2.33 |
| 2011 | 2.26 |
| 2010 | 2.14 |
| 2009 | 1.72 |
| 2008 | 1.81 |
| 2007 | 2.46 |
| 2006 | 2.18 |
| 2005 | 2.15 |
| 2004 | 1.67 |
Orion Oyj Aktienanalyse
What does Orion Oyj do?
Orion Oyj is a Finnish company that was founded in 1917 as a pharmacy in Turku. Today, Orion Oyj is a leading manufacturer of diagnostic tests, medicines, and other health products. Business model: Orion Oyj focuses on four core areas: Pharmaceutical, Diagnostics, Animal Health, and Fermion. The Pharmaceutical segment is the largest market and includes the production and sale of prescription drugs in the therapy areas of central nervous system disorders, oncology, respiratory diseases, and urology. Orion also produces generics of prescription drugs. The Diagnostics segment includes the development and production of in vitro diagnostic tests (IVDs) for clinical laboratories and point-of-care facilities. Animal Health manufactures products for animal health. Fermion produces active ingredients and intermediates for use in Orion's own and other pharmaceutical companies. Products: Orion offers a wide range of health products. The key products in the pharmaceutical segment are levodopa-based Parkinson's drugs (Stalevo, Comtess, and Opicapone) and drugs for the treatment of asthma and chronic obstructive pulmonary diseases (Easyhaler product family). ORIAHNN (Eligolix and estradiol capsules) was approved by the FDA as the first oral medication for the treatment of uterine fibroids in premenopausal women. In animal health, Orion Oyj offers products focused on the treatment of pet skin diseases, eye and ear infections, and parasite infestations. Orion also has a wide range of IVD products. The focus is on infection diagnostics, offering a wide range of medical tests to detect infections such as hepatitis B, hepatitis C, HIV, tuberculosis, human papillomavirus, and other sexually transmitted diseases. In the diagnostics segment, Orion also produces devices used in blood tests and other tests in hospitals and clinical laboratories. Future prospects: Orion Oyj is expected to invest more in the IVD segment in the coming years. The company sees significant growth potential here and plans to launch new products and test kits on the market. In addition, Orion also invests in spin-off companies focusing on the research and development of promising new technologies and therapies. Orion Oyj has been a leading player in the healthcare market for years. With a wide range of products and a strong focus on research and development, the company has built a solid foundation for future success. Orion Oyj ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Orion Oyj's Market Capitalization
Orion Oyj's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Orion Oyj's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Orion Oyj's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Orion Oyj’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Orion Oyj stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Orion Oyj.
How has the market capitalization of Orion Oyj developed in recent years?
The market capitalization of Orion Oyj has increased/decreased by 30.71% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Orion Oyj?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Orion Oyj?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Orion Oyj have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Orion Oyj pay?
Over the past 12 months, Orion Oyj paid a dividend of 1.6 EUR . This corresponds to a dividend yield of about 3.25 %. For the coming 12 months, Orion Oyj is expected to pay a dividend of 1.73 EUR.
What is the dividend yield of Orion Oyj?
The current dividend yield of Orion Oyj is 3.25 %.
When does Orion Oyj pay dividends?
Orion Oyj pays a quarterly dividend. This is distributed in the months of April, April, April, November.
How secure is the dividend of Orion Oyj?
Orion Oyj paid dividends every year for the past 23 years.
What is the dividend of Orion Oyj?
For the upcoming 12 months, dividends amounting to 1.73 EUR are expected. This corresponds to a dividend yield of 3.52 %.
In which sector is Orion Oyj located?
Orion Oyj is assigned to the 'Health' sector.
Wann musste ich die Aktien von Orion Oyj kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Orion Oyj from 10/23/2024 amounting to 0.81 EUR, you needed to have the stock in your portfolio before the ex-date on 10/15/2024.
When did Orion Oyj pay the last dividend?
The last dividend was paid out on 10/23/2024.
What was the dividend of Orion Oyj in the year 2023?
In the year 2023, Orion Oyj distributed 1.5 EUR as dividends.
In which currency does Orion Oyj pay out the dividend?
The dividends of Orion Oyj are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Orion Oyj
Our stock analysis for Orion Oyj Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orion Oyj Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
